Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.19 USD | +2.34% | +14.73% | +57.63% |
May. 13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
May. 13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.63% | 525M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- TScan Therapeutics Files $300 Million Mixed-Securities Shelf